Evidence map›Paper›PMID 29769160›Full record

ArticleEpidemiology and infection2018

Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania.

O Popovici, Ph Monk, D Chemtob, D Chiotan, P J Freidlin, R Groenheit, M Haanperä, D Homorodean, M Mansjö, E Robinson and 4 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

O PopoviciNational Institute of Public Health, National Centre for Surveillance and Control of Communicable Diseases, Bucuresti, Romania.
Ph MonkPublic Health England East Midlands Centre, Nottingham, England.
D ChemtobMinistry of Health, Department of Tuberculosis (TB) and AIDS and National TB Programme manager, Jerusalem, Israel.
D ChiotanNational Institute of Pulmonology "Marius Nasta", Bucuresti, Romania.
P J FreidlinMinistry of Health, Public Health Services, National Public Health Laboratories, Tel Aviv, Israel.
R GroenheitPublic Health Agency of Sweden, WHO Supranational TB Reference Laboratory, Solna, Sweden.
M HaanperäDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
D HomorodeanNational Reference Laboratory for Tuberculosis Cluj-Napoca, Romania.
M MansjöPublic Health Agency of Sweden, WHO Supranational TB Reference Laboratory, Solna, Sweden.
E RobinsonPublic Health England, National Infection Service, Public Health Laboratory, Birmingham, England.
E RormanMinistry of Health, Public Health Services, Director National Public Health Laboratories, Tel Aviv, Israel.
G SmithPublic Health England, Director National Mycobacteriology Reference Service, National Infection Service, Public Health Laboratory, Birmingham, England.
H SoiniDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
M J Van Der WerfEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensively drug-resistant (XDR) tuberculosis (TB) poses a threat to public health due to its complicated, expensive and often unsuccessful treatment. A cluster of three XDR TB cases was detected among foreign medical students of a Romanian university. The contact investigations included tuberculin skin testing or interferon gamma release assay, chest X-ray, sputum smear microscopy, culture, drug susceptibility testing, genotyping and whole-genome sequencing (WGS), and were addressed to students, personnel of the university, family members or other close contacts of the cases. These investigations increased the total number of cases to seven. All confirmed cases shared a very similar WGS profile. Two more cases were epidemiologically linked, but no laboratory confirmation exists. Despite all the efforts done, the source of the outbreak was not identified, but the transmission was controlled. The investigation was conducted by a team including epidemiologists and microbiologists from five countries (Finland, Israel, Romania, Sweden and the UK) and from the European Centre for Disease Prevention and Control. Our report shows how countries can collaborate to control the spread of XDR TB by exchanging information about cases and their contacts to enable identification of additional cases and transmission and to perform the source investigation.

Indexed as

AdolescentCluster AnalysisContact TracingDisease OutbreaksEuropeExtensively Drug-Resistant TuberculosisFamilyFemaleHumansIsraelMaleRomaniaStudents, MedicalYoung AdultContact tracingextensively drug-resistanttuberculosiswhole genome sequencing

Identifiers

PMID29769160
PMCPMC9184956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.